Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 2729Lung Neoplasms 945Small Cell Lung Carcinoma 447Neoplasms 419Colorectal Neoplasms 409Breast Neoplasms 355Melanoma 332Ovarian Neoplasms 316Neoplasm Metastasis 281Pancreatic Neoplasms 252Squamous Cell Carcinoma of Head and Neck 232Stomach Neoplasms 227Carcinoma, Renal Cell 214Triple Negative Breast Neoplasms 190Head and Neck Neoplasms 178Prostatic Neoplasms 152Esophageal Neoplasms 149Endometrial Neoplasms 145Uterine Cervical Neoplasms 139Urinary Bladder Neoplasms 132Mesothelioma 115Carcinoma 106Colonic Neoplasms 104Carcinoma, Hepatocellular 104Sarcoma 99Carcinoma, Transitional Cell 99Kidney Neoplasms 74Mesothelioma, Malignant 72Cholangiocarcinoma 67Liver Neoplasms 66

Interventions

efatutazone 1Nivolumab 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Advanced Non-small Cell Lung Cancer (NSCLC) × Thoracic × Clear all
NCT07590531 2026-05-15

AMT-116 in Combination With Ivosidan in Patients With Lung Cancer

Multitude Therapeutics Inc.

Phase 1/2 Not yet recruiting
118 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer (NSCLC)

NCT02175017 2024-12-09

ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

Ono Pharmaceutical Co., Ltd.

Phase 2 Completed
104 enrolled 21 charts
Thoracic

Advanced Non-small Cell Lung Cancer (NSCLC)

NCT01101334 2020-06-16

Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer

Daiichi Sankyo

Phase 2 Completed
90 enrolled 11 charts
Thoracic

Advanced Non-small Cell Lung Cancer (NSCLC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡